A longitudinal study of abnormalities on MRI and disability from multiple sclerosis.
暂无分享,去创建一个
David H. Miller | O. Ciccarelli | A. Thompson | M. Sailer | J. O'riordan | P. Brex | David H. Miller | A. Thompson | A. Thompson
[1] G. Beebe,et al. Studies on the natural history of multiple sclerosis--8. Early prognostic features of the later course of the illness. , 1977, Journal of chronic diseases.
[2] G. Aimard,et al. Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. , 1980, Brain : a journal of neurology.
[3] J. H. Steiger. Tests for comparing elements of a correlation matrix. , 1980 .
[4] D. Silberberg,et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.
[5] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[6] D. Paty,et al. CORRELATION BETWEEN NMR SCAN AND BRAIN SLICE DATA IN MULTIPLE SCLEROSIS , 1984, The Lancet.
[7] R. Kakigi,et al. Disseminated lesions at presentation in patients with optic neuritis. , 1986, Journal of neurology, neurosurgery, and psychiatry.
[8] D. MacManus,et al. Magnetic resonance imaging in clinically isolated lesions of the brain stem. , 1986, Journal of neurology, neurosurgery, and psychiatry.
[9] P. Sandercock,et al. Magnetic resonance imaging in isolated noncompressive spinal cord syndromes , 1987, Annals of neurology.
[10] W. Mcdonald,et al. A reassessment of the risk of multiple sclerosis developing in patients with optic neuritis after extended follow-up. , 1987, Journal of neurology, neurosurgery, and psychiatry.
[11] J. Rizzo,et al. Risk of developing multiple sclerosis after uncomplicated optic neuritis , 1988, Neurology.
[12] B E Kendall,et al. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. , 1988, Brain : a journal of neurology.
[13] B E Kendall,et al. The early risk of multiple sclerosis after optic neuritis. , 1988, Journal of neurology, neurosurgery, and psychiatry.
[14] I. Moseley,et al. The early risk of multiple sclerosis following isolated acute syndromes of the brainstem and spinal cord , 1989, Annals of neurology.
[15] B Bass,et al. The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. , 1989, Brain : a journal of neurology.
[16] S. Holtås,et al. A long‐term prospective study of optic neuritis: Evaluation of risk factors , 1990, Annals of neurology.
[17] Douglas G. Altman,et al. Practical statistics for medical research , 1990 .
[18] Robert Tibshirani,et al. An Introduction to the Bootstrap , 1994 .
[19] D. Miller,et al. The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study. , 1993, Brain : a journal of neurology.
[20] O. Andersen,et al. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. , 1993, Brain : a journal of neurology.
[21] D. Paty,et al. Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis , 1993, Neurology.
[22] J. Taubenberger,et al. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis , 1993, Annals of neurology.
[23] H. Lassmann,et al. Histopathology and the blood–cerebrospinal fluid barrier in multiple sclerosis , 1994, Annals of neurology.
[24] S. Reingold,et al. Defining the clinical course of multiple sclerosis , 1996, Neurology.
[25] A. Thompson,et al. Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. , 1996, Brain : a journal of neurology.
[26] F. Barkhof,et al. Interscanner variation in brain MRI lesion load measurements in MS: Implications for clinical trials , 1997, Neurology.
[27] V. Perry,et al. Axonal damage in acute multiple sclerosis lesions. , 1997, Brain : a journal of neurology.
[28] G. Comi,et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. , 1997, Brain : a journal of neurology.
[29] G. Barker,et al. The effect of section thickness on MR lesion detection and quantification in multiple sclerosis. , 1998, AJNR. American journal of neuroradiology.
[30] P M Matthews,et al. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. , 1998, Brain : a journal of neurology.
[31] A. Thompson,et al. The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. , 1998, Brain : a journal of neurology.
[32] R. Rudick,et al. Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.
[33] A J Thompson,et al. Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination. , 1999, Neurology.
[34] V. Torri,et al. Long-term follow-up of isolated optic neuritis: the risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests , 1999, Journal of Neurology.
[35] C Confavreux,et al. Relapses and progression of disability in multiple sclerosis. , 2000, The New England journal of medicine.
[36] S. Miller,et al. Temporal Development of Autoreactive Th1 Responses and Endogenous Presentation of Self Myelin Epitopes by Central Nervous System-Resident APCs in Theiler’s Virus-Infected Mice1 , 2000, The Journal of Immunology.
[37] J H Simon,et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. , 2000, The New England journal of medicine.
[38] A. Compston,et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.
[39] Marco Rovaris,et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study , 2001, The Lancet.